{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-010644","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.785382+00:00","generated_at":"2026-05-31T13:33:00.756978+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Owens & Minor Q2 revenue up 4% to $2.7B; adjusted EPS doubles to $0.36; agrees to acquire Rotech","bullets":["Revenue $2.67B (+4% YoY); GAAP net loss $32M ($0.42 loss per share) vs. $28M loss last year.","Adjusted EBITDA $127M (+12% YoY); adjusted EPS $0.36 vs. $0.18, doubling year over year.","Operating cash flow $116M used to reduce debt by $71M during the quarter.","Agreement to acquire Rotech Healthcare Holdings to expand Patient Direct segment; expected close H2 2024.","Management reaffirms full-year 2024 adjusted EBITDA guidance of $515M-$545M."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-010644","json":"https://secwatch.observer/filing/0001558370-24-010644.json","markdown":"https://secwatch.observer/filing/0001558370-24-010644.md","text":"https://secwatch.observer/filing/0001558370-24-010644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000155837024010644/0001558370-24-010644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000155837024010644/tmb-20240802x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:33:00.756978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}